Skip to search formSkip to main contentSkip to account menu

AGM 1470

Known as: AGM-1470 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

O-(chloroacetylcarbamoyl)fumagillol
TNP 470

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma.
We demonstrated recently that chronic frequent administration of an adequate biological dose of the angiogenesis inhibitor TNP… 
2003
2003
Preparation of poly-lactic acid microspheres containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles.
Highly Cited
2002
Highly Cited
2002
Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary…
PURPOSE The angiogenic inhibitor TNP-470 (AGM-1470, O-chloracetyl-carbamoyl fumagillol) has been reported to inhibit the growth… 
1999
1999
Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects
The efficacy of cis-diammine dichloroplatinum (CDDP) therapy in combination with continuous administration of angiogenesis… 
1998
1998
Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470)
Abstract Objective To evaluate the efficacy of the angiogenesis inhibitor AGM-1470 for the experimental treatment of… 
1996
1996
The angiogenesis inhibitor AGM-1470 selectively increases E-selectin.
The levels of E-selectin mRNA and protein were analyzed in bovine capillary cells treated with or without the angiogenesis… 
1996
1996
In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor.
AGM-1470, a potent angiogenesis inhibitor, is already engaged in phase I clinical trials because of its effectiveness to restrain… 
1996
1996
Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
We examined whether lymphatic metastasis was inhibited by the potent angiogenesis inhibitor AGM-1470 [O-(chloroacetyl-carbamoyl… 
1994
1994
The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model.
Angiogenesis is a process fundamental to the growth of many solid tumours. Agents that inhibit angiogenesis may have a role in… 
1994
1994
Inhibition of vascular endothelial growth-factor induced cell-growth by an angiogenesis inhibitor agm-1470 in capillary endothelial-cells.
It is known that an anti-angiogenic compound AGM-1470 inhibits cells in vitro and in vivo, on mitogen-induced cell growth in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)